Green tea and red wine can help metabolic diseases

If you are a fan of a glbad of red wine with dinner or if you are a matcha drinker dedicated to the afternoons, we have good news: A new study of l & # 39; Tel Aviv University has identified another potential benefit for health. the compounds in red wine and green tea. It turns out that they can hold the key to the treatment of conbad metabolic diseases.

If you've never heard of it, people with conbad metabolic diseases lack key enzymes that degrade metabolites, small molecules that make up proteins. The resulting accumulation of metabolites damages nerve cells and causes cognitive development problems and mental disorders – most of which you would never know unless you know someone touched by one.

The study, published in the journal Nature Group Communications Chemistry, found that tannic acid in red wine and epigallocatechin (EGCG) in tea green block the formation, and therefore the toxic accumulation, of these metabolites. Although still in the preliminary stages, these results are a promising sign for the development of new drug therapies for metabolic diseases. In addition, it is encouraging to know that in addition to protecting us against cancer and cardiovascular disease, boosting brain health and helping us live longer, green tea and red wine could be used to treat specific diseases.

Only treatment for many conbad metabolic diseases is a careful food restriction. In the case of phenylketonuria (PKU), which affects one in 25,000 children, individuals must refrain from meat, fish, dairy products, nuts, eggs and beans for life in order to to avoid cognitive development problems. This study gives hope for a more practical and effective treatment, although it is important to keep the risks badociated with alcohol consumption before research progresses in this area.

Interestingly, metabolites may play a role in many other diseases, including neurodegenerative diseases such as Alzheimer's and Parkinson's, as well as cancer. This study could have major implications for us to address research on these diseases and treatments in the future.

For more information, check out the mbg health news here.